Survey of attitude to human genome modification in Nigeria

Armsby AJ, Bombard Y, Garrison NA, Halpern-Felsher BL, Ormond KE (2019) Attitudes of members of genetics professional societies toward human gene editing. CRISPR J 2(5):331. https://doi.org/10.1089/CRISPR.2019.0020

Article  PubMed  PubMed Central  Google Scholar 

Buchholzer M, Frommer WB (2023) An increasing number of countries regulate genome editing in crops. New Phytol 237(1):12–15. https://doi.org/10.1111/NPH.18333

Article  PubMed  Google Scholar 

Claiborne A, English R, Kahn J (2016) Mitochondrial replacement techniques: ethical, social, and policy considerations. Washington, DC, The National Academic Press. https://doi.org/10.17226/21871

ClinicalTrials (2023) Search for: Gene Therapy | Card Results | ClinicalTrials.Gov. https://clinicaltrials.gov/search?cond=Gene%20Therapy. Accessed 24 Oct 2023

Coller BS (2019) Ethics of human genome editing. Annual Rev Med 70:289–305. https://doi.org/10.1146/Annurev-Med-112717-094629

Article  CAS  Google Scholar 

Critchley C, Nicol D, Bruce G, Walshe J, Treleaven T, Tuch B (2019) Predicting public attitudes toward gene editing of germlines: the impact of moral and hereditary concern in human and animal applications. Front Genet 10(JAN):704. https://doi.org/10.3389/FGENE.2018.00704/BIBTEX

Article  Google Scholar 

Delhove J, Osenk I, Prichard I, Donnelley M (2020) Public acceptability of gene therapy and gene editing for human use: a systematic review. Hum Gene Ther 31(1–2):20–46. https://doi.org/10.1089/HUM.2019.197

Dickler HB, Collier E (1994) Gene therapy in the treatment of disease. J Allergy Clin Immunol 94(6):942–951. https://doi.org/10.1016/0091-6749(94)90111-2

Doudna JA, Charpentier E (2014) The new frontier of genome engineering with CRISPR-Cas9. Science 346:1258096. https://doi.org/10.1126/SCIENCE.1258096

Ekechi-Agwu CA, Nwafor AO (2020) Regulating assisted reproductive technologies (ART) in Nigeria: lessons from Australia and the United Kingdom. Afr J Reprod Health 24(4):82–93. https://doi.org/10.29063/AJRH2020/V24I4.9

Article  PubMed  Google Scholar 

Funk C, Kennedy B, Sciupac EP (2016) U.S. public wary about use of biomedical technology for human enhancement. Pew Research Center. https://www.pewresearch.org/science/2016/07/26/u-s-public-wary-ofbiomedical-technologies-to-enhance-human-abilities/. Accessed 24 Oct 2023

Geuverink W, van El C, Cornel M, Lietaert Peerbolte BJ, Gitsels J, Martin L (2023) Between desire and fear: a qualitative interview study exploring the perspectives of carriers of a genetic condition on human genome editing. Humanit Soc Sci Commun 10:477. https://doi.org/10.1057/S41599-023-01935-0

Hariharan S, Jonnalagadda R, Walrond E, Moseley H (2006) Knowledge, attitudes and practice of healthcare ethics and law among doctors and nurses in Barbados. BMC Med Ethics 7:7. https://doi.org/10.1186/1472-6939-7-7

Hendriks S, Giesbertz NAA, Bredenoord AL, Repping S (2018) Reasons for being in favour of or against genome modification: a survey of the Dutch general public. Hum Reprod Open 2018(3):hoy008. https://doi.org/10.1093/HROPEN/HOY008

Holdren JP, Sunstein CR, Siddiqui IA (2011) Principles for regulation and oversight of emerging technologies. Obama White House Archives. https://obamawhitehouse.archives.gov/sites/default/files/omb/inforeg/foragencies/Principles-for-Regulation-and-Oversight-of-Emerging-Technologies-new.pdf. Accessed 24 Oct 2023

Houtman D, Geuverink W, Helmrich IRAR, Vijlbrief B, Cornel M, Riedijk S (2023) “What if” should precede “whether” and “how” in the social conversation around human germline gene editing. J Community Genet 14(4):371–375. https://doi.org/10.1007/S12687-023-00652-0/FIGURES/1

Article  PubMed  PubMed Central  Google Scholar 

Hudson J, Orviska M (2011) European attitudes to gene therapy and pharmacogenetics. Drug Discov Today 16(19–20):843–847. https://doi.org/10.1016/J.DRUDIS.2011.06.008

Article  PubMed  Google Scholar 

Idoko-Akoh A, Goldhill DH, Sheppard CM, Bialy D, Quantrill JL, Sukhova K, Brown JC, Richardson S, Campbell C, Taylor L, Sherman A, Nazki S, Long JS, Skinner MA, Shelton H, Sang HM, Barclay WS, McGrew MJ (2023) Creating resistance to avian influenza infection through genome editing of the ANP32 gene family. Nature Commun 14(1):1–15. https://doi.org/10.1038/s41467-023-41476-3

Article  CAS  Google Scholar 

Izzah SN, Setyanto D, Hasanatuludhhiyah N, Indiastuti DN, Nasution Z, D’Arqom A (2021) Attitudes of Indonesian medical doctors and medical students toward genome editing. J Multidiscip Healthc 14:1017–1027. https://doi.org/10.2147/JMDH.S303881

Article  PubMed  PubMed Central  Google Scholar 

Jasanoff S, Hurlbut J, Saha K (2015) Crispr democracy: gene editing and the need for inclusive deliberation. Issues Sci Technol 32(1):25–32

Google Scholar 

Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E (2012) A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337(6096):816–821. https://doi.org/10.1126/SCIENCE.1225829/SUPPL_FILE/JINEK.SM.PDF

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kupferschmidt K (2023) Shadowed by past, gene-editing summit looks to future. Science 379(6637):1073–1074. https://doi.org/10.1126/SCIENCE.ADH7972

Article  CAS  PubMed  Google Scholar 

McCaughey T, Sanfilippo PG, Gooden GEC, Budden DM, Fan L, Fenwick E, Rees G, MacGregor C, Si L, Chen C, Liang HH, Baldwin T, Pébay A, Hewitt AW (2016) A global social media survey of attitudes to human genome editing. Cell Stem Cell 18(5):569–572. https://doi.org/10.1016/J.STEM.2016.04.011

Article  CAS  PubMed  Google Scholar 

Miyaoka Y, Berman JR, Cooper SB, Mayerl SJ, Chan AH, Zhang B, Karlin-Neumann GA, Conklin BR (2016) Systematic quantification of HDR and NHEJ reveals effects of locus, nuclease, and cell type on genome-editing. Sci Rep 6(1):1–12. https://doi.org/10.1038/srep23549

Article  CAS  Google Scholar 

Mulvihill JJ, Capps B, Joly Y, Lysaght T, Zwart HAE, Chadwick R (2017) Ethical issues of CRISPR technology and gene editing through the lens of solidarity. Br Med Bull 122(1):17–29. https://doi.org/10.1093/bmb/ldx002

Article  PubMed  Google Scholar 

Okonta PI, Ajayi R, Bamgbopa K, Ogbeche R, C.okeke C, Onwuzurigbo K (2018) Ethical issues in the practice of assisted reproductive technologies in Nigeria: empirical data from fertility practitioners. Afr J Reprod Health 22(3):51–58

PubMed  Google Scholar 

Ormond KE, Mortlock DP, Scholes DT, Bombard Y, Brody LC, Faucett WA, Garrison NA, Hercher L, Isasi R, Middleton A, Musunuru K, Shriner D, Virani A, Young CE (2017) Human germline genome editing. Am J Hum Genet 101(2):167–176. https://doi.org/10.1016/J.AJHG.2017.06.012

Article  CAS  PubMed  PubMed Central  Google Scholar 

Papathanasiou S, Markoulaki S, Blaine LJ, Leibowitz ML, Zhang CZ, Jaenisch R, Pellman D (2021) Whole chromosome loss and genomic instability in mouse embryos after CRISPR-Cas9 genome editing. Nature Commun 12(1):1–7. https://doi.org/10.1038/s41467-021-26097-y

Article  CAS  Google Scholar 

Patra S (2015) Effects of genetic engineering - the ethical and social implications. Ann Clin Lab Res 3(1):1–2. https://doi.org/10.21767/2386-5180.10005

Article  Google Scholar 

Ranisch R, Trettenbach K, Arnason G (2023) Initial heritable genome editing: mapping a responsible pathway from basic research to the clinic. Med Health Care Philos 26(1):21–35. https://doi.org/10.1007/S11019-022-10115-X/FIGURES/1

Article  PubMed  Google Scholar 

Reardon S (2016) Welcome to the CRISPR zoo. Nature 531(7593):160–163. https://doi.org/10.1038/531160a

Article  CAS  PubMed  Google Scholar 

Redman M, King A, Watson C, King D (2016) What is CRISPR/Cas9? Arch Dis Child Educ Pract Ed 101(4):213–215. https://doi.org/10.1136/archdischild-2016-310459

Article  PubMed  PubMed Central  Google Scholar 

Report of the House Committee on Environment and Habitat (2019) National Assembly of Nigeria. https://placng.org/i/wp-content/uploads/2019/12/Report-of-the-House-of-Reps-Committee-on-Environment-and-Habitat-on-National-Biosafety-Management-Agency-Act-Amendment-Bill-2018.pdf. Accessed 24 Oct 2023

Rothschild J (2020) Ethical considerations of gene editing and genetic selection. J Gen Fam Med 21(3):37–47. https://doi.org/10.1002/JGF2.321

Article  PubMed  PubMed Central  Google Scholar 

Scheufele DA, Krause NM, Freiling I, Brossard D (2021) What we know about effective public engagement on CRISPR and beyond. Proc Natl Acad Sci USA 118(22):e2004835117. https://doi.org/10.1073/PNAS.2004835117/ASSET/B85631BC-3F6C-4B25-8715-6874BBDD88B4/ASSETS/IMAGES/LARGE/PNAS.2004835117FIG02.JPG

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sharma H, Singh D, Mahant A, Sohal SK, Kesavan AK (2020) Development of mitochondrial replacement therapy: a review. Heliyon 6(9):e04643. https://doi.org/10.1016/j.heliyon.2020.e04643

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tachibana M, Kuno T, Yaegashi N (2018) Mitochondrial replacement therapy and assisted reproductive technology: a paradigm shift toward treatment of genetic diseases in gametes or in early embryos. Reprod Med Biol 17(4):421–433. https://doi.org/10.1002/rmb2.12230

Article  PubMed  PubMed Central  Google Scholar 

Vajen B, Ronez J, Rathje W, Heinisch L, Ebeling S, Gebhard U, Hößle C, Schlegelberger B (2021) Students’ attitudes towards somatic genome editing versus genome editing of the germline using an example of familial leukemia. J Community Genet 12(3):397–406. https://doi.org/10.1007/S12687-021-00528-1

Article  PubMed  PubMed Central  Google Scholar 

Wang J-H, Wang R, Lee JH, Iao TWU, Hu X, Wang Y-M, Tu L-L, Mou Y, Zhu W-L, He A-Y, Zhu S-Y, Cao D, Yang L, Tan X-B, Zhang Q, Liang G-L, Tang S-M, Zhou Y-D, Feng L-J, ... Liu G-S (2017) Public attitudes toward gene therapy in China. Mol Ther Methods Clin Dev 6:40–42. https://doi.org/10.1016/j.omtm.2017.05.008

Weisberg SM, Badgio D, Chatterjee A (2017) A CRISPR new world: attitudes in the public toward innovations in human genetic modification. Front Public Health 5:117. https://doi.org/10.3389/FPUBH.2017.00117/BIBTEX

Article  PubMed  PubMed Central  Google Scholar 

Wise J (2023) First baby born in the UK using mitochondrial donation therapy. BMJ 381:p1091. https://doi.org/10.1136/BMJ.P1091

Article  Google Scholar 

Zaboikin M, Zaboikina T, Freter C, Srinivasakumar N (2017) Non-homologous end joining and homology directed DNA repair frequency of double-stranded breaks introduced by genome editing reagents. Plos One 12(1):e0169931. https://doi.org/10.1371/JOURNAL.PONE.0169931

Article  PubMed  PubMed Central  Google Scholar 

Zarghamian P, Klermund J, Cathomen T (2023) Clinical genome editing to treat sickle cell disease-A brief update. Front Med 9:1065377. https://doi.org/10.3389/FMED.2022.1065377

Zhang F, Wen Y, Guo X (2014) CRISPR/Cas9 for genome editing: progress, implications and challenges. Hum Mol Genet 23(R1):R40–R46. https://doi.org/10.1093/HMG/DDU125

Article  CAS 

留言 (0)

沒有登入
gif